SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 90 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $75,000 | +74.4% | 47,595 | +121.2% | 0.01% | +66.7% |
| Q2 2022 | $43,000 | -94.3% | 21,521 | -93.3% | 0.01% | -94.0% |
| Q1 2022 | $748,000 | +364.6% | 321,129 | +825.4% | 0.10% | +400.0% |
| Q4 2021 | $161,000 | -40.4% | 34,701 | -1.9% | 0.02% | -28.6% |
| Q3 2021 | $270,000 | +26.8% | 35,363 | +37.0% | 0.03% | -20.0% |
| Q1 2021 | $213,000 | +69.0% | 25,808 | +40.1% | 0.04% | +66.7% |
| Q4 2020 | $126,000 | -77.5% | 18,418 | -76.4% | 0.02% | -25.0% |
| Q2 2018 | $561,000 | -53.8% | 77,895 | -66.9% | 0.03% | -56.2% |
| Q1 2018 | $1,213,000 | +1361.4% | 235,495 | +1283.7% | 0.06% | +1180.0% |
| Q4 2016 | $83,000 | -20.2% | 17,019 | +42.6% | 0.01% | 0.0% |
| Q4 2015 | $104,000 | -88.9% | 11,933 | -89.4% | 0.01% | -89.1% |
| Q3 2015 | $940,000 | +214.4% | 112,067 | +332.9% | 0.05% | +283.3% |
| Q1 2015 | $299,000 | – | 25,889 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 15,001 | $1,410 | 0.00% |
| KLCM Advisors, Inc. | 20,000 | $1,880 | 0.00% |
| AlphaMark Advisors, LLC | 3,135 | $0 | 0.00% |
| TRUST CO OF VERMONT | 204 | $19 | 0.00% |
| SlateStone Wealth, LLC | 30,866 | $3 | 0.00% |
| Coppell Advisory Solutions LLC | 100 | $89 | 0.00% |
| Highlander Capital Management, LLC | 1,200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Russell Investments Group, Ltd. | 266 | $25 | 0.00% |
| OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,600 | $0 | 0.00% |